Effect of anti-inflammatory and antioxidant drugs on the long-term repair of severely injured mouse skeletal muscle

Experimental Physiology

Volumn 90, Issue 4, 2005, Pages 487-495

  Vignaud, A ^a   Cebrian, J ^a   Martelly, I ^a   Caruelle, J P ^a   Ferry, A ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CURCUMIN; DICLOFENAC; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; MYOSIN HEAVY CHAIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; CRUSH TRAUMA; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOBLOTTING; LETHALITY; MALE; MOUSE; MUSCLE CELL; MUSCLE FORCE; MUSCLE INJURY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE REGENERATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; TISSUE REPAIR;

EID: 22144476811     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.2005.029835     Document Type: Article

References (45)

1. Almekinders LC (1993). Anti-inflammatory treatment of muscular injuries in sports. Sports Med 15, 139-145.
2. Almon RR & Dubois DC (1990). Fiber-type discrimination in disuse and glucocorticoid-induced atrophy. Med Sci Sports Exerc 22, 304-311.
3. Asai A & Miyazawa T (2001). Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131, 2932-2935.
4. Blau HM & Epstein CJ (1979). Manipulation of myogenesis in vitro: reversible inhibition by DMSO. Cell 17, 95-108.
5. Bondesen BA, Mills ST, Kegley KM & Pavlath GK (2004). The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol 287, C475-C483.
6. Brickson S, Ji LL, Schell K, Olabisi R, St Pierre Schneider B & Best TM (2003). M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury. J Appl Physiol 95, 969-976.
7. Chaudiere J & Ferrari-Ilion R (1999). Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 37, 949-962.
8. Cheung EV & Tidball JG (2003). Administration of the nonsteroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use. Inflamm Res 52, 170-176.
9. Connolly DA, Sayers SP & McHugh MP (2003). Treatment and prevention of delayed onset muscle soreness. J Strength Cond Res 17, 197-208.
10. Gabe M (1968). Techniques Histologiques. Masson, Paris, France.
11. Gao F, Yao CL, Gao E, Mo QZ, Yan WL, McLaughlin R, Lopez BL, Christopher TA & Ma XL (2002). Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 301, 543-550.
12. Guttridge DC, Mayo MW, Madrid LV, Wang CY & Baldwin AS Jr (2000). NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363-2366.
13. Harris JB, Vater R, Wilson M & Cullen MJ (2003). Muscle fibre breakdown in venom-induced muscle degeneration. J Anat 202, 363-372.
14. Hirose J, Yamaga M, Kato T, Ikebe K & Takagi K (2001). Effects of a hydroxyl radical scavenger, EPC-K1, and neutrophil depletion on reperfusion injury in rat skeletal muscle. Acta Orthop Scand 72, 404-410.
15. Hodel C (2002). Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 128, 159-168.
16. Horsley V & Pavlath GK (2003). Prostaglandin F2 (α) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J Cell Biol 161, 111-118.
17. Jacob SW & Herschler R (1986). Pharmacology of DMSO. Cryobiology 23, 14-27.
18. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S et al. (2000). Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87, 392-398.
19. Kranz H, Brazeau G, Napaporn J, Martin R, Millard W & Bodmeier R (2001). Myotoxicity of injectable biodegradable in situ forming drug delivery systems. Int J Pharmaceutics 212, 11-18.
20. Kumar A, Lnu S, Malya R, Barron D, Moore J et al (2003). Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. Faseb J 17, 1800-1811.
21. Lapointe BM, Fremont P & Cote CH (2003). Influence of nonsteroidal anti-inflammatory drug treatment duration and time of onset on recovery from exercise-induced muscle damage in rats. Arch Plays Med Rehabil 84, 651-655.
22. Lapointe BM, Frenette J & Cote CH (2002). Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion. J Appl Physiol 92, 1995-2004.
23. Lefaucheur JP & Sebille A (1995). The cellular events of injured muscle regeneration depend on the nature of the injury. Neuromuscul Disord 5, 501-509.
24. Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D, Zampieri M et al. (1999). Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord 9, 72-80.
25. Lille ST, Lefler SR, Mowlavi A, Suchy H, Boyle EM Jr, Farr AL et al. (2001). Inhibition of the initial wave of NF-κB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve 24, 534-541.
26. McLoughlin TJ, Tsivitse SK, Edwards JA, Aiken BA & Pizza FX (2003). Deferoxamine reduces and nitric oxide synthase inhibition increases neutrophil-mediated myotube injury. Cell Tissue Res 313, 313-319.
27. Merly F, Lescaudron L, Rouaud T, Crossin F & Gardahaut MF (1999). Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22, 724-732.
28. Mishra DK, Friden J, Schmitz MC & Lieber RL (1995). Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am 77, 1510-1519.
29. Mitchell C, Grounds M & McGeachie J (1991). The effect of low dose dexamethasone on skeletal muscle regeneration in vivo. BAM 2, 139-144.
30. Miyabara EH, Tostes RC, Selistre de Araujo HS, Aoki MS, Salvini TF & Moriscot AS (2004). Cyclosporin A attenuates skeletal muscle damage induced by crotoxin in rats. Toxicon 43, 35-42.
31. Nguyen HX & Tidball JG (2003). Null mutation of gp91 phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol 553, 833-841.
32. Noirez P, Agbulut O & Ferry A (2000). Effet d'un médicament anti-inflammatoire non-stéroïdien sur la régéné ration musculaire chez le rat. Sci Sports 15, 165-167.
33. Noirez P, Ben Salah I, Le Page C, Daegelen D & Ferry A (1999). Effects of glucocorticid treatment on regenerating skeletal muscles in the rat. Sci Sports 14, 153-155.
34. Obremsky WT, Seaber AV, Ribbeck BM & Garrett WE Jr (1994). Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med 22, 558-561.
35. Pimorady-Esfahani A, Grounds MD & McMenamin PG (1997). Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve 20, 158-166.
36. 2α influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257, 1632-1638.
37. Summan M, McKinstry M, Warren GL, Hulderman T, Mishra D, Brumbaugh K et al. (2003). Inflammatory mediators and skeletal muscle injury: a DNA microarray analysis. J Interferon Cytokine Res 23, 237-245.
38. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS et al. (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480-481, 243-268.
39. Tegeder I, Pfeilschifter J & Geisslinger G (2001). Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J 15, 2057-2072.
40. Teixeira CF, Zamuner SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fernandes I et al. (2003). Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 28, 449-459.
41. Thaloor D, Miller KJ, Gephart J, Mitchell PO & Pavlath GK (1999). Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol 277, C320-C329.
42. Tidball JG (1995). Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 27, 1022-1032.
43. 2 in response to eccentric resistance exercise: influence of ibuprofen acetaminophen. J Clin Endocrinol Metab 86, 5067-5070.
44. Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, Luster MI et al. (2004). Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol 286, C1031-C1036.
45. Zerba E, Komorowski TE & Faulkner JA (1990). Free radical injury to skeletal muscles of young, adult, and old mice. Am J Physiol 258, C429-C435.